baber/WOPTO huggingface dataset:
Patent NZ-311574-A (NZ)
Title: Method of modifying enteral composition by including a chamber having at least one beneficial agent therein through which the enteral composition flows
Inventor: GECKLE RONITA KAY
IPC: A61K9/22
Filed: 1996-01-03
Abstract: A method is disclosed for modifying a liquid enteral nutritional product during delivery thereof from a supply container to a feeding tube delivering the nutritional product to the gastrointestinal tract of a patient. During enteral tube feeding the nutritional product passes through a formulation chamber, e.g., a drip chamber, having located therein at least one controlled release dosage form unit containing at least one beneficial agent. The beneficial agent may be selected from nutrients, medicaments, probiotics, or diagnostic agents or mixtures thereof, and any such together with a physiologically acceptable marker dye in controlled release dosage form and/or the same or different additional beneficial agent not in controlled release dosage form. Controlled release dosage forms may be of a conventional sustained release type or an osmotically driven delivery device.
Patent NZ-332019-A (NZ)
Title: High water content porous polymer comprising a perfluoropolyether unit
Inventor: CHAOUK HASSAN
IPC: C09D171/02
Filed: 1997-03-20
Abstract: A porous polymer prepared under porosity-promoting condition as defined in the specification comprising one or more perfluoropolyether units having a water content when fully swollen in water which is higher than that of the same polymer if polymerized under conventional conditions is claimed. The perfluoropolyether units are preferably of the formula (PFPE):-OCH2-CF2O(CF2CF2O)x-(CF2O)y-CF2CH2O- wherein the CF2CF2O and CF2O units may be randomly distributed or distributed as blocks throughout the chain and wherein x and y may be the same or different such that the molecular weight of the perfluorinated polyether is in the range of from 242 to 4,000. The porous polymers are suitable for soft contact lenses.
Patent NZ-332559-A (NZ)
Title: 3-mercapto-propylamine substituted 4-carbonylamino-5,5-dimethyl-thiazolidine derivatives
Inventor: DONG ZHENG XIN
IPC: C07D277/02
Filed: 1997-05-06
Abstract: The thiazolidine derivatives have the formula I or II or a pharmaceutically acceptable salt thereof wherein: R1 is H or NR20R21; R2 is -(CH2)m-SR22, -(CH2)m-SSR22 or optionally substituted heterocycle or heterocycle alkyl; m is 1-6; each of R3 and R7 are independently CH2 or C(O); each of R4 and R15 is independently H or alkyl; each of R5 and R16 is independently H or optionally substituted alkyl, thioalkyl, alkenyl, thioalkenyl, cycloalkyl, cycloalkylalkyl, aryl or aralkyl; each of R6, R8, R9, R11, R12, R13 and R17 is independently H or optionally substituted alkyl, thioalkyl, alkenyl, cycloalkyl, cycloalkylalkyl, aryl or aralkyl; R10 is -S-, -S(O) or -S(O)2-; R18 is -COOR27 or -C(O)NR28R29 or together with R16 form a -COO-CH2-CH2-; R19 is optionally substituted alkyl, alkenyl, aryl or aralkyl and R20-R29 is H or alkyl provided that if R2 is -(CH2)m-SH and R5 is thioalkyl, the free thio groups of R2 and R5 can form a disulphide bond. The compounds are useful in the treatment of tumours or restenosis.
Patent NZ-332856-A (NZ)
Title: Fastening screw, drilling tip having a cutting edge, a flute and threads
Inventor: ROBERTS DAVID JAMES ALEXANDER
IPC: F16B25/08
Filed: 1998-11-18
Abstract: A fastening screw, for fastening metal sheet to timber, has an elongate shank 1 and a drilling tip 2 and a head 3 provided at respective opposite ends of the shank.  The shank tapers to the tip 2.  The tip 2 has a pair of cutting edges 5 disposed on opposite sides of the longitudinal axis of the shank and a flute 6 extending longitudinally of the shank from each of the cutting edges.  A thread 8 is formed on the shank and extends from adjacent tip 2 rearwardly to beyond the section of the shank in which the flutes are formed.
Patent NZ-337842-A (NZ)
Title: Broadband loudspeakers with diagonal rear deflection plate and enclosure shell being odd-sided polygon in section
Inventor: KOPPEN DETLEF
IPC: H04R9/06
Filed: 1998-03-17
Abstract: A broadband loudspeaker emits in an approximately punctiform manner and whose movable components are secured to a dome-shaped loudspeaker front which, at the rear, opens into a housing shell disposed coaxially around the centre axis of the housing. Opposite the rear side of the diaphragm lies a diagonal deflection plane which can take the form of a rear wall. The inner cross-section of the housing shell is preferably designed as an irregular polygon, as is the dome-shaped loudspeaker front and the preferably cup-shaped loudspeaker diaphragm which can be secured directly to the loudspeaker front.
Patent NZ-505954-A (NZ)
Title: A process for preparing 2-pyridylmethylamine derivatives; their use as fungicides; and intermediates thereof
Inventor: MOLONEY BRIAN ANTHONY
IPC: C07D213/85
Filed: 1999-02-16
Abstract: Described are compounds of formula (I) and salts thereof as phytopathogenic fungicides, wherein: A1 is substituted 2-pyridyl; A2 is optionally substituted phenyl; L is -(C=O) -, -SO2- or - (C=S) -; R1 is hydrogen, optionally substituted alkyl or acyl; and R2 is hydrogen or optionally substituted alkyl are useful phytopathogenic fungicides.
Patent NZ-512861-A (NZ)
Title: Removable core cylinder lock
Inventor: WIDEN BO
IPC: E05B9/06
Filed: 2000-01-21
Abstract: A removable core cylinder lock, comprising a casing (10), a lock core (20) with a rotatable key plug (30) in a cylindrical bore (23) and retaining means adapted to releasably retain the lock core in an inserted position in the casing. The casing has two lugs (14, 15) extending radially inwards and being separated transversely from each other, whereas the lock core has two corresponding recesses (27, 28) on both sides of a central, rear portion, whereby the lock core can be fully inserted into said casing. The two lugs are provided with means for fastening the casing to an object.
Patent NZ-513578-A (NZ)
Title: Pyridazin-3-one derivatives and medicines containing the same
Inventor: OHKUCHI MASAO
IPC: A61P37/06
Filed: 2000-02-25
Abstract: Pyridazin-3-one derivatives of general formula (I) or salts of the same, exhibiting an excellent interleukin-1 beta production inhibiting effect; and medicines containing the derivatives or the salts as the active ingredient are disclosed, wherein: Ar1 is an optionally substituted aromatic group; Ar2 is phenyl substituted at least at the 4-position; R1 is linear or branched alkyl, alkyl having a cyclic structure, optionally substituted phenyl, or optionally substituted phenyl lower alkyl; and R2 is cyano, carboxyl, lower alkoxycarbonyl, optionally substituted lower alkyl, or optionally substituted carbamoyl.
Patent NZ-517467-A (NZ)
Title: Flax seed specific promoters and methods for specifically expressing genes of interest in flax seeds
Inventor: CHAUDHARY SARITA
IPC: C12N15/82
Filed: 2000-08-25
Abstract: Disclosed are methods for the expression of non-native genes in flax seeds and the seeds of other plant species are provided. The methods involve the use of seed-specific promoters obtained from flax. Additionally provided are flax seed-specific promoters, chimeric nucleic acid constructs comprising flax seed-specific promoters, transgenic plant cells, transgenic plants and transgenic plant seeds containing flax seed-specific promoters. The promoters and methods are useful, for example, for altering the seed oil and protein composition in flax seed or other plant seeds.
Patent NZ-520263-A (NZ)
Title: Esters derived from (RR,SS)-3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl 2-hydroxybenzoate and their use for the treatment of pain
Inventor: HUGUET CLOTET JUAN
IPC: A61P25/04
Filed: 2000-12-26
Abstract: The compound of formula (I), where: R1 is halogen, C1-C6 alkyl which is unsubstituted or substituted partially or totally by halogen, OR3, NO2 or aryl which is unsubstituted or partially or totally substituted by halogen, where R3 is C1-C6 alkyl. R2 is H or CH3CO-. Also described are pharmaceutical compositions comprising the compound of formula (I). The compounds of formula (I) are useful for the treatment of pain.
Patent NZ-524851-A (NZ)
Title: Apparatus and method for packaging products into varying sized bags
Inventor: PALUMBO RICCARDO
IPC: B65B5/04
Filed: 2001-10-05
Abstract: An apparatus for packaging products having different shape and dimensions, such as for example food products of different size, into pre-formed bags of appropriate size, such as for example heat-shrinkable bags of thermoplastic material, comprises a conveyor (2) for carrying in sequence a plurality of products (3) to be packaged from a product loading portion (2a) to a product packaging bracket end portion (2b) thereof, means (5) for detecting the dimensions of each product to be packaged while it moves from said product loading portion to said product packaging bracket end portion of said at least one conveyor and a plurality of bag dispensing devices (6) for dispensing a plurality of bags (4) varying in at least one dimension thereof. The apparatus also comprises means for automatically selecting a bag dispensing device from said plurality of bags dispensing devices, depending on the detected product dimensions, and means (7) for picking-up a bag from the selected bag dispensing device and positioning it around the product packaging bracket end portion of said at least one conveyor thus packaging the product present thereon. A method for packaging products by means of an apparatus of the type above described is also disclosed.
Patent NZ-526913-A (NZ)
Title: Inhibitors of cruzipain and other cysteine proteases
Inventor: QUIBELL MARTIN
IPC: A61P43/00
Filed: 2002-01-17
Abstract: A compound according to general formula (I) or general formula (II) useful as an inhibitor of the protease cruzipain, a gene product of the Trypanosoma cruzi parasite, as well as other cysteine proteases. Also disclosed are pharmaceutical compositions comprising such compounds, useful for the therapeutic treatment of Trypanosoma cruzi infection, for example, in Chagas' disease.
Patent NZ-527813-A (NZ)
Title: Systems and methods for dispensing postage stamps
Inventor: LORD DANIEL J
IPC: G07B17/00
Filed: 2002-02-25
Abstract: A system for dispensing postage stamps comprises: a point of sale terminal for receiving payment from a customer for a postage value; means for requesting and receiving an authorization key from an authorization system; means for providing the authorization key to the customer; and means for providing postage stamps equivalent to the postage value from a postage dispensing machine when the authorization key is provided to the postage dispensing machine. The means for requesting and receiving an authorization key from an authorization system can be a means for sending a request electronically to the authorization system wherein the point of sale terminal transmits to the authorization system information related to the postage value and a point of sale terminal identifier. The means for providing the authorization key to the customer can be a means for printing the authorization key on a receipt. The means for providing postage stamps equivalent to the postage value from a postage dispensing machine when the authorization key is provided to the postage dispensing machine can comprises: a means for sending a verification electronically to the authorization system to verify the authorization key wherein the postage dispensing machine transmits to the authorization system information related to the authorization key and a postage dispensing machine identifier and a means for printing postage stamps equivalent to the postage value from the postage dispensing machine when the authorization system verifies the authorization key.
Patent NZ-532800-A (NZ)
Title: Foamed article with absorbing characteristics on one side and non-absorbing characteristics on the other side and method for producing same
Inventor: OWENSBY JOSEPH E
IPC: B29C44/00
Filed: 2004-05-07
Abstract: A multilayer foam article comprising a pair of foam outer layers having open cells and closed cells. An inner layer is disposed between the pair of foam outer layers which are co-extruded with the inner layer and also has open cells adjacent the inner layer. A method of forming the foam article is also disclosed comprising preparing a polymer melt and co-extruding the various layers to form the article.
Patent NZ-534728-A (NZ)
Title: A method, system and software for managing software licence annuities
Inventor: JACKSON WAYNE ALBERT
Filed: 2004-08-16
Abstract: A computer-implemented method of modelling software licence renewal options, including annuity renewal options. Licensing scenarios are displayed in graphical form.
Patent NZ-534864-A (NZ)
Title: Human monoclonal antibodies to dentritic cells
Inventor: DEO YASHWANT M
IPC: A61K47/48
Filed: 2001-05-08
Abstract: An isolated human monoclonal antibody, or an antigen-binding portion, that specifically binds to human dendritic cells which induces cytokine release and thus modulates the dendritic cells. This antibody can be used in the manufacture of a medicament to induce or enhance an immune response or to treat or prevent an autoimmune disease, a graft verses host disease or to inhibit tumor growth. (62) Divided Out of 522643
Patent NZ-536908-A (NZ)
Title: Treating or preventing cancer comprising administering an effective amount of cytokine inhibitory drug plus a second active ingredient
Inventor: ZELDIS JEROME B
IPC: A61K31/425
Filed: 2003-05-16
Abstract: Disclosed is the use of a selective cytokine inhibitory drug selected from cyclopropanecarboxylic acid {2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide of the structure shown and pharmaceutically acceptable salts and solvates thereof; in the preparation of a composition for treating non-Hodgkin's lymphoma.
Patent NZ-538532-A (NZ)
Title: Polypeptides involved in the regulation of flowering in forage grasses
Inventor: DEMMER JEROEN
IPC: C07K14/415
Filed: 2003-09-04
Abstract: Described are isolated polynucleotides encoding polypeptides that regulate flowering, together with expression vectors and host cells comprising such isolated polynucleotides. Methods for the use of such polynucleotides and polypeptides are also provided.
Patent NZ-540208-A (NZ)
Title: Treatment of headache with antipsychotics delivered by inhalation
Inventor: HALE RON L
IPC: A61K31/553
Filed: 2003-11-20
Abstract: The use of prochlorperazine in the manufacture of an inhalation administered medicament for the treatment of headache in a patient in need of headache relief, wherein the medicament contains prochlorperazine as the only headache relief agent and is formulated such that the peak plasma concentration of the prochlorperazine is obtained within 15 minutes of initiation of administration of the prochiorperazine. The aforementioned medicament is particularly suitable for treating a migraine headache, a tension-type headache, or a cluster headache.
Patent NZ-540233-A (NZ)
Title: Nociceptin analogs for the treatment of pain
Inventor: SUN QUN
IPC: A61P9/12
Filed: 2002-04-18
Abstract: A compound of formula (III) that is useful for modulating a pharmacodynamic response from opioid receptors centrally and/or peripherally is disclosed, wherein: Z, D, R, R1, R2, and n are as described in the specification. These compounds are suitable for treating chronic and acute pain.
Patent NZ-541933-A (NZ)
Title: Method and apparatus for establishing an invite-first communication session
Inventor: ROSS DAVID JONATHAN
IPC: H04W4/06
Filed: 2004-02-20
Abstract: A method for establishing an invite-first communication session in a wireless communication network is disclosed. The method comprises: (a) Receiving an invite message from an inviter; (b) Forwarding the invite message to at least one invitee, where the invite message indicates that an acceptance is required from the invitee to establish the communication session; (c) Receiving the acceptance response from the invitee in response to the invite message, where the invitee selects to accept the invitation; and (d) Establishing a communication session between the inviter and the invitee.
Patent NZ-550339-A (NZ)
Title: Modified bouganin proteins, cytotoxins and methods and uses thereof
Inventor: BAKER MATTHEW
IPC: C12N15/29
Filed: 2005-03-18
Abstract: A modified bouganin protein and process for producing a bouganin protein wherein said modified bouganin has a reduced propensity to activate an immune response wherein said bouganin has an amino acid substitution at one or more of X1 , X2 , X3 , X4 or X5 in a T-cell epitope selected from the group consisting of: a) AKX1 DRKX2LX3LGVX4KL (SEQ ID NO:5) b) (SEQ ID NO:6); and c) NGQEX5AKFFLIVIQM (SEQ ID NO:7) wherein X1 through X5 can be any amino acid. A cytotoxin comprising a targeting moiety and modified bouganin is disclosed. Uses of the cyclotoxin include treating cancer.
Patent NZ-550899-A (NZ)
Title: Double nuclear transfer method and the production of a non human animal thereby
Inventor: CAMPBELL KEITH H S
IPC: A61K48/00
Filed: 2000-01-13
Abstract: A method is described for the production of an animal offspring by the process of nuclear transfer. The animal may be produced using donor genetic material in cells taken directly from any stage of an animal, such as an embryo, foetus or adult or from cell cultures established from material from any stage of an animal, such as embryonic, foetal or adult material. The process may be used to introduce genetic modifications into the resultant offspring by genetic manipulation and selection of the cells to act as nuclear donors prior to embryo reconstruction. Disclosed is a method of reconstituting an animal embryo, the process comprising transferring a nucleus into a first oocyte followed by removing and transferring said nucleus from said oocyte to a further oocyte or to an enucleated fertilised zygote.
Patent NZ-552799-A (NZ)
Title: Risedronate compositions and their methods of use
Inventor: BURGIO DAVID ERNEST
IPC: A61K31/663
Filed: 2004-09-25
Abstract: The use of risedronate in the manufacture of a medicament for treating or preventing a bone disorder in a human wherein the medicament is for oral administration of about 65% to about 110% of the cumulative effective dose of risedronate according to a continuous dosing schedule of one day per month, wherein the one day per month dosage is in the form of a unit dose tablet comprising from about 100 to about 165 mg risedronte.
Patent NZ-553777-A (NZ)
Title: Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
Inventor: MEYER ADAM GERHARD
IPC: A01N41/06
Filed: 2005-09-21
Abstract: Disclosed are trifluoromethanesulfonanilide compounds or their pharmaceutically acceptable salts or solvates thereof, wherein the trifluoromethanesulfonanilide compound corresponds to the structure of general formula (I), and wherein the substituents are as defined herein. Also disclosed is a pharmaceutical composition for the treatment of animals infected with parasites (such as an arthropod or helminth) that comprises a therapeutically effective dosage amount of the trifluoromethanesulfonanilide compound as defined above, and a pharmaceutically acceptable excipient.
Patent NZ-555500-A (NZ)
Title: Crystalline forms of levosalbutamol sulfate, process for their preparation, and their use in respiratory conditions
Inventor: LULLA AMAR
IPC: A61K9/12
Filed: 2005-12-19
Abstract: Disclosed are three crystalline forms (polymorphs) of levosalbutamol sulfate, characterised by powder XRD patterns as described in the specification. Also disclosed are processes to prepare each of the crystalline forms, and the use of the forms for treating respiratory conditions such as bronchoconstriction, asthma, and COPD.
Patent NZ-562587-A (NZ)
Title: Patient cooling system
Inventor: WHYTE DAVID
IPC: A61F7/00
Filed: 2003-11-05
Abstract: A patient cooling system comprises a patient enclosure or tent (2) having a coaxial hose connection (46, 4, 6) to a re-circulating air-cooling system (16, 18, 24). The hose comprises an inner tube (4) to introduce air into the enclosure and an outer tube (16) for the return air. The patient cooling system further comprises a patient-supporting mattress (42) comprising a plurality of inflatable compartments (A, B) extending transversely across the width of the mattress, which can also be supplied with cooled air. The compartments (A, B) can be alternately pressurized for pressure relief therapy. Moreover, the compartments can be pressurized either with relatively low pressure cold air from the air cooling system, or with higher pressure air which acts to support the patient, but provides relatively less cooling effect.
Patent NZ-567546-A (NZ)
Title: Method for preparing a beverage from a capsule
Inventor: OZANNE MATTHIEU
IPC: B65D81/00
Filed: 2006-10-02
Abstract: A method for preparing a beverage through a capsule (2) inserted in a beverage machine; the capsule comprising an enclosure containing one or more beverage ingredients (5), wherein a brewing fluid is introduced in the enclosure to brew the said one or more beverage ingredients, wherein a brewed liquid is filtered by a filtering wall (22) and delivered from the capsule, wherein the filtering wall extends from substantially the bottom of the enclosure and said filtering wall is associated to an overflow wall (3) that forces the brewed liquid to traverse at least one overflow aperture (25). The method is particularly suitable for brewing a tea containing capsule.
Patent NZ-578549-A (NZ)
Title: New classical antifolates
Inventor: ROBERTS MICHAEL J
IPC: A61K31/519
Filed: 2008-01-18
Abstract: Discloses is a diaminopyrollo[2,3-d]pyrimidine derivative of the pictures formula, or a pharmaceutically acceptable ester, amide, salt, solvate, or enantiomer thereof, wherein X is CHR9 or NR9, and wherein the other substituents are as defined in the specification. Also disclosed is the use of the compound for treating abnormal cell proliferation, inflammation, asthma, and arthritis.
Patent NZ-579692-A (NZ)
Title: Programmable on screen display and remote control
Inventor: MADONNA Robert
IPC: G06F3/038
Filed: 2008-03-14
Abstract: Disclosed is a method for programming a programmable remote control comprising the steps of: defining functions that a user may initiate by pressing buttons on a physical remote control or touch screen display; storing information representing the functions; displaying a graphical programming environment; using the graphical programming environment in conjunction with a first graphics file with layers of graphics that indicate a function is assigned to at least one of the buttons, the function to be performed when the at least one of the buttons is pressed in connection with a first predetermined on screen display being shown on a display device separate from the physical remote control or touchscreen; using the graphical programming environment in conjunction with a second graphics file with layers of graphics that indicate a different function is assigned to the at least one of the buttons, the different function to be performed in response to the user navigating with the physical remote control or touchscreen to a second predetermined on screen display shown on the display device separate from the physical remote control or touchscreen and the user pressing the at least one of the buttons in connection with the second predetermined on screen display being shown; using software to parse the first graphics file or the second graphics file to extract the layers of graphics that indicate the function or the different function is assigned to the at least one of the buttons; and passing commands to an application programming interface (API) to cause the function or the different function to be performed.